Windward Bio Group AG IPO: offering terms from its F-1
Windward Bio Group AG filed its F-1 on 23 Oct 2026 to list on Nasdaq as WWB. It has not set a price range yet.
Headlines
- Net loss, 2025
- $48M
- Price range
- Not set yet
Windward Bio Group AG IPO terms
From the newest registration statement. Terms left blank there are not set yet.
- Exchange
- Nasdaq Global Market
- Ticker
- WWB
- Price range
- Not set yet
- Shares offered
- Not set yet
- Expected to raise
- Not set yet
- Registered
- $100M, the amount the filing fee is paid on
- Underwriters
- Jefferies, TD Cowen, Piper Sandler and UBS Investment Bank
- First filed
- 23 Oct 2026
Windward Bio Group AG revenue and profit
| Period | Revenue | Operating income | Net income |
|---|---|---|---|
| 2025 | - | -$52M | -$48M |
| First half of 2026 | - | -$45M | -$43M |
Windward Bio Group AG share structure and company facts
- Employees
- 38
- Headquarters
- Basel, Switzerland
Windward Bio Group AG's IPO filings
The registration statement, each amendment and the final prospectus, oldest first.
| Filed | Form |
|---|---|
| 23 Oct 2026 | F-1 |
About the data
- Terms and financials are read from Windward Bio Group AG's newest prospectus (F-1 filed 23 Oct 2026) by a Kadoa workflow. Check figures that matter against the filing.
- Registered is the amount the filing fee is paid on, often a placeholder before the price range is set.
- Raised is the IPO price times the shares sold, without the underwriters' option. Trading compares the first and latest close with the IPO price.